Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2003
05/01/2003WO2003014362A3 Method for producing a marker-free mutated target organism and plasmid vectors suitable for the same
05/01/2003WO2003008623A3 Methylation analysis using nicking agents
05/01/2003WO2003008622A3 Exponential nucleic acid amplification using nicking endonucleases
05/01/2003WO2003008597A3 Regulation of peroxisomal fatty acid transport in plants
05/01/2003WO2003007677A3 Thermal cycling system and method of use
05/01/2003WO2003006675A3 Methods and devices based upon a novel form of nucleic acid duplex on a surface
05/01/2003WO2003004685A3 Soluble steroidal peptides for nucleic acid delivery
05/01/2003WO2003000881A3 Method of plasmid stabilisation by in vivo deleting the antibiotic resistence and selecting with an essential gene
05/01/2003WO2002101022A3 Method for rapid amplification of dna
05/01/2003WO2002100336A3 Tissue-specific endothelial membrane proteins
05/01/2003WO2002100199A3 Modifying nicotine and nitrosamine levels in tobacco
05/01/2003WO2002099055A3 Cips as modifiers of the p53 pathway and method of use
05/01/2003WO2002099046A3 Spo11 as modifier of the p53 pathway and methods of use
05/01/2003WO2002098897A3 Modified antibodies to prostate-specific membrane antigen and uses thereof
05/01/2003WO2002098444A3 Use of hepcidin for preparing a medicament for treating disorders of iron homeostasis
05/01/2003WO2002095053A3 Antisense modulation of src-c expression
05/01/2003WO2002092798A3 Regulation of human phosphatidic acid phosphatase type 2c-like protein
05/01/2003WO2002092741A3 0etergent compositions comprising bacillus subtilis pectate lyases
05/01/2003WO2002090553A3 Recombinant fusion proteins and the trimers thereof
05/01/2003WO2002090498A3 A high throughput assay for identification of gene expression modifiers
05/01/2003WO2002085293A3 Production of alpha-lipoic acid
05/01/2003WO2002083734A3 Modified calcitonin
05/01/2003WO2002083712A3 Transporters and ion channels
05/01/2003WO2002083183A3 Stimulation of the immune system
05/01/2003WO2002081513A3 Disease-associated protein
05/01/2003WO2002077231A3 Nucleic acid-associated proteins
05/01/2003WO2002076391A3 Microbial feeds for aquaculture and agriculture
05/01/2003WO2002074917A3 Method for modifying a biological pathway
05/01/2003WO2002074806A3 New interferon beta-like molecules
05/01/2003WO2002074799A3 Pepsin-sensitive modified bacillus thuringiensis insecticidal toxin
05/01/2003WO2002072887A3 Immobilisation of ligands using saccharides
05/01/2003WO2002072755A3 Polynucleotide encoding a novel human g-protein coupled receptor, hgprbmy27
05/01/2003WO2002070548A3 Modified human granulocyte macrophage colony stimulating factor (gm-csf) with reduced immunogenicity
05/01/2003WO2002068668A3 Compositions and methods for production cell culture
05/01/2003WO2002068471A3 Nucleic acid molecules and polypeptides for a human cation channel polypeptide
05/01/2003WO2002066645A3 Mutant pro-neurotrophin with improved activity
05/01/2003WO2002064783A3 Novel cofactors of the estrogen receptor beta and methods of use
05/01/2003WO2002064761A3 Regulation of human long chain polyunsaturated fatty acid elongation enzyme-like protein
05/01/2003WO2002063007A3 TIMM8b-RELATED PROTEIN
05/01/2003WO2002062378A3 Hyperblebbing bacterial strains and use thereof for production of vaccines
05/01/2003WO2002060939A8 Method for increasing the sulphur-compound content in plants
05/01/2003WO2002059356A3 Method for screening compounds for activity in treating an osteoclast related bone disease
05/01/2003WO2002059322A9 Compositions and methods relating to the daptomycin biosynthetic gene cluster
05/01/2003WO2002059296A3 Concatemers of differentially expressed multiple genes
05/01/2003WO2002057471A3 Maize chloroplast aldolase promoter compositions and methods for use thereof
05/01/2003WO2002057456A3 Regulators of fungal gene expression
05/01/2003WO2002057433A3 Homeodomain-interacting protein kinases and the use of the same for influencing cell division and cell proliferation
05/01/2003WO2002055703A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/01/2003WO2002055679A3 Thermostable lipolytic enzyme variant
05/01/2003WO2002053750A3 Inactivation of the polyphosphate kinase gene for microbial overproduction of antibiotics or enzymes
05/01/2003WO2002053741A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
05/01/2003WO2002053586A3 Inhibitor of apoptosis proteins and nucleic acids and methods for making and using them
05/01/2003WO2002048385A3 Compositions and methods for the release of nucleic acid molecules from solid matrices
05/01/2003WO2002046476A3 Genotyping using partially-complementary probes
05/01/2003WO2002046463A9 Nucleic acid extraction method and kit
05/01/2003WO2002044407A3 Glyphosate resistant transgenic sugar beet characterised by a specific transgene insertion (t227-1), methods and primers for the detection of said insertion
05/01/2003WO2002044392A3 Dna encoding a plant deoxyhypusine synthase, a plant eukaryotic initiation factor 5a, transgenic plants and a method for controlling senescence programmed and cell death in plants
05/01/2003WO2002044391A9 Methods and compositions for the introduction of molecules into cells
05/01/2003WO2002042460A3 Compositions and methods relating to colon specific genes and proteins
05/01/2003WO2002040687A3 Tissue specific promoters from the sugar beet
05/01/2003WO2002040544A9 Mutant human factor ix with an increased resistance to inhibition by heparin
05/01/2003WO2002038600A3 C. elegans genes involved in viability and/or reproduction and uses thereof
05/01/2003WO2002036783A3 Regulation of human histone deacetylase
05/01/2003WO2002034910A3 Method for modulating granzyme b uptake and for identifying modulators thereof
05/01/2003WO2002031149A9 Polyvalent cation-sensing receptor proteins in aquatic species
05/01/2003WO2002031148A3 Mammalian wnt polypeptide-5
05/01/2003WO2002029093A3 Method for selecting nucleic acids that bond with high-affinity to a target
05/01/2003WO2002027023A3 Genetic determinants for dermal inflammation and immunity
05/01/2003WO2002026956A9 Calcium free subtilisin mutants
05/01/2003WO2002026250A3 Vaccines for proliferative ileitis
05/01/2003WO2002020811A3 Modified tet-inducible system for regulation of gene expression in plants
05/01/2003WO2002016572A3 Nucleic acid molecules, methods and kits for selecting a nucleic acid having a desired feature
05/01/2003WO2002012466A3 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
05/01/2003WO2002004671A3 Improved binding interactions in dipstick assays
05/01/2003WO2001098478A3 Clk-2, cex-7 and coq-4 genes, and uses thereof
05/01/2003WO2001098346A3 Methods and compositions for the treatment of peripheral artery disease
05/01/2003WO2001079291A3 Secreted proteins
05/01/2003WO2001066572A3 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof
05/01/2003WO2001024681A3 Alterations in the long qt syndrome genes kvlqt1 and scn5a and methods for detecting same
05/01/2003WO2000071564A3 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
05/01/2003US20030084487 Methods for transforming coffee plants to suppress expression of coffee fruit-expressed ACC synthase and/or coffee fruit-expressed ACC oxidase necessary for ethylene biosynthesis and ripening of coffee fruit
05/01/2003US20030084486 Root-preferred promoters and their use
05/01/2003US20030084485 Comprising overexpressing a molybdenum cofactor sulfurase in the plant; improving drought resistance, freeze resistance, salt tolerance of plants
05/01/2003US20030084484 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins
05/01/2003US20030084483 Methods and means for modification of plant characteristics
05/01/2003US20030084482 Particularly proteins that in their native state require the coordinate expression of a plurality of structural genes in order to become biologically active; therapy, medical diagnosis
05/01/2003US20030084480 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acid levels
05/01/2003US20030084479 Nucleic acid encoding a homogentisate phytyltransferase and a sequence encoding a plastid transit peptide, functionally linked to regulatory signals which ensure transcription and translation in prokaryotic or eukaryotic organisms
05/01/2003US20030084478 Plants having enhanced gall resistance and methods and ocmpositions for producing same
05/01/2003US20030084477 Genes enhancing disease resistance in plants
05/01/2003US20030084476 DNA polymerase eta ( Poleta) cDNA and uses thereof
05/01/2003US20030084475 Nucleic acid fragments and proteins affecting storage organelle formation and methods of use
05/01/2003US20030084474 Antibiotics-independent vector for constant high-expression and method for gene expression using the same
05/01/2003US20030084473 Non-transgenic herbicide resistant plants
05/01/2003US20030084472 Useful for genetic manipulation of plant characteristics, identification, isolation and introduction of genes useful for altering seed oil content, seed size, flowering and/or generation time, or vegetative growth of commercial crops
05/01/2003US20030084471 Methods and compositions for RNA interference
05/01/2003US20030084470 Nucleic acid encoding GAI gene of arabidopsis thaliana
05/01/2003US20030084468 Methods of expressing transgenes
05/01/2003US20030084467 Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints
05/01/2003US20030084463 Method for the production of a protein
1 ... 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 2541 2542 2543 2544 2545 2546 2547 2548 2549 ... 4023